BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15737895)

  • 1. Iron requirements in erythropoietin therapy.
    Eschbach JW
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):347-61. PubMed ID: 15737895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron metabolism in rhEPO-treated hemodialysis patients.
    Schaefer RM; Bahner U
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S65-8. PubMed ID: 10746809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
    Gasche C; Waldhoer T; Feichtenschlager T; Male C; Mayer A; Mittermaier C; Petritsch W;
    Am J Gastroenterol; 2001 Aug; 96(8):2382-7. PubMed ID: 11513178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
    Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing iron status: beyond serum ferritin and transferrin saturation.
    Wish JB
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J; Gregora E; Lachmanová J; Brabec V
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The biochemical and hematological assessment of iron metabolism].
    Nathanson S; Deschênes G; Bensman A
    Arch Pediatr; 1999 Nov; 6(11):1199-204. PubMed ID: 10587746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
    Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
    Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating iron status in hemodialysis patients.
    Enders HM
    Nephrol Nurs J; 2002 Aug; 29(4):366-70. PubMed ID: 12224370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
    J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia of chronic disease: pathophysiology and laboratory diagnosis.
    Thomas C; Thomas L
    Lab Hematol; 2005; 11(1):14-23. PubMed ID: 15790548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin, iron metabolism, and red blood cell production.
    Adamson J
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):5-7; discussion 8-9. PubMed ID: 8723573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of iron deficiency in patients undergoing hemodialysis.
    Buttarello M; Pajola R; Novello E; Rebeschini M; Cantaro S; Oliosi F; Naso A; Plebani M
    Am J Clin Pathol; 2010 Jun; 133(6):949-54. PubMed ID: 20472854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of iron status and iron supplementation in patients treated with erythropoietin.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 1994 Nov; 3(6):620-5. PubMed ID: 7881986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patients.
    Rutkowski B; Debska-Slizień A; Biedunkiewicz B; Bułło B
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():17-21. PubMed ID: 8192528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kondakhchan MA; Rogov VA; Trofimova EI
    Ter Arkh; 1993; 65(6):45-8. PubMed ID: 8378849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double diagnostic meaning of serum transferrin receptor in hemodialysis patients: two case reports.
    Passanante S; Diquattro M; Greco V; Li Cavoli G; Bono L; Palma B; Scola S; Faraci C; Rotolo U; Menozzi I
    Lab Hematol; 2004; 10(2):61-4. PubMed ID: 15224760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G; Gârneata L; Capusa C; Ursea N
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.